Which has grown faster, ADMA or RXRX?

Over the past five years, ADMA grew revenue faster — ADMA at a 54.55% CAGR versus RXRX at 45.50%.

Is ADMA or RXRX more profitable?

ADMA runs the higher net margin — ADMA at 32.98% versus RXRX at -945.92%.

How have ADMA and RXRX total returns compared?

Over the past 5 years, ADMA delivered 54.74% and RXRX delivered -25.86% annualized total return. Past performance doesn't predict future results.

ADMA Biologics, Inc. (ADMA) vs Recursion Pharmaceuticals, Inc. (RXRX)

A side-by-side comparison of ADMA Biologics, Inc. and Recursion Pharmaceuticals, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

ADMA

ADMA Biologics, Inc.

$2.34B

$10.11HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT

RXRX

Recursion Pharmaceuticals, Inc.

$2.51B

$4.78HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT

Total return — ADMA vs RXRX

growth of $100 · dividends reinvested · last 5y

ADMA +487.8% (+42.5%/yr)RXRX -73.4% (-23.3%/yr)ADMA compounded faster over this window

Log scale — wide-divergence pair

ADMA RXRX

ADMA vs RXRX: by the numbers

•RXRX is the larger company ($2.51B vs $2.34B market cap).
•ADMA is profitable (32.98% net margin) while RXRX runs a net loss (-945.92%).
•ADMA grew revenue faster over the past five years (54.55% vs 45.50% CAGR).

Metrics side by side

Valuation

Metric	ADMA	RXRX
P/E ratio	14.44	N/A
Forward P/E	12.69	N/A
P/S ratio	4.57	45.72
P/B ratio	5.74	2.74
EV / EBITDA	10.67	N/A
FCF yield	4.97%	N/A

Profitability

Metric	ADMA	RXRX
Gross margin	64.71%	-61.96%
Operating margin	42.26%	-867.87%
Net margin	32.98%	-945.92%
ROE	41.39%	-56.71%
ROIC	27.60%	-49.78%

Growth (annualized)

Metric	ADMA	RXRX
Revenue CAGR (5Y)	54.55%	45.50%
Total return CAGR (5Y)	54.74%	-25.86%

Frequently asked

Which has grown faster, ADMA or RXRX?: Over the past five years, ADMA grew revenue faster — ADMA at a 54.55% CAGR versus RXRX at 45.50%.
Is ADMA or RXRX more profitable?: ADMA runs the higher net margin — ADMA at 32.98% versus RXRX at -945.92%.
How have ADMA and RXRX total returns compared?: Over the past 5 years, ADMA delivered 54.74% and RXRX delivered -25.86% annualized total return. Past performance doesn't predict future results.

Go deeper

Full ADMA analysis Full RXRX analysis Interactive comparison tool

Dig into the metrics

ADMA Biologics P/E ratio ADMA Biologics ROE Recursion Pharmaceuticals ROE ADMA Biologics operating margin Recursion Pharmaceuticals operating margin ADMA Biologics revenue growth Recursion Pharmaceuticals revenue growth ADMA Biologics free cash flow Recursion Pharmaceuticals free cash flow

ADMA Biologics & Recursion Pharmaceuticals appear in these rankings

Fastest Revenue Growth Stocks Highest ROE Stocks Highest ROIC Stocks Highest Operating Margin Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.